85 related articles for article (PubMed ID: 27755932)
1. Residual or Retained Gadolinium.
Ben Salem D; Ognard J; Guiu B
Radiology; 2016 Nov; 281(2):650-651. PubMed ID: 27755932
[No Abstract] [Full Text] [Related]
2. Residual or retained gadolinium: practical implications for radiologists and our patients.
Kanal E; Tweedle MF
Radiology; 2015 Jun; 275(3):630-4. PubMed ID: 25942418
[No Abstract] [Full Text] [Related]
3. Evaluation of residual acoustic schwannoma using gadolinium-DTPA enhanced magnetic resonance imaging with the fat suppression technique.
Battista RA; Bojrab DI; Wang AM
Am J Otol; 1995 Sep; 16(5):628-33. PubMed ID: 8588668
[TBL] [Abstract][Full Text] [Related]
4. Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imaging.
Channual S; Pahwa A; Lu DS; Raman SS
Abdom Radiol (NY); 2016 Sep; 41(9):1825-41. PubMed ID: 27225503
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of residual tumor from benign periablational tissues after radiofrequency ablation: the role of MR imaging contrast agents.
Ni Y; Chen F; Marchal G
Radiology; 2005 Nov; 237(2):745-7; author reply 748-9. PubMed ID: 16244283
[No Abstract] [Full Text] [Related]
6. Porphyrin-containing Gadolinium Complex as a Tumor-targeting Magnetic Resonance Imaging (MRI) Contrast Agent.
Ouyang YH; Xu W; Zhou CK; Liu F; Li B; Yan GP; Yang L; Chen S; Jiang C
Curr Drug Deliv; 2018; 15(7):972-978. PubMed ID: 29629659
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium-DTPA in the magnetic resonance evaluation of the postoperative patient. Work in progress.
Sze G; Berry I; Brant-Zawadzki M; Dillon WP; Olsen WL; Norman D; Newton TH
Acta Radiol Suppl; 1986; 369():568-71. PubMed ID: 2980560
[TBL] [Abstract][Full Text] [Related]
8. Choosing the Safest Gadolinium-based Contrast Medium for MR Imaging: Not So Simple after All.
Davenport MS
Radiology; 2018 Feb; 286(2):483-485. PubMed ID: 29356642
[No Abstract] [Full Text] [Related]
9. Macrocyclic Versus Linear Gadolinium Chelates.
Runge VM
Invest Radiol; 2015 Dec; 50(12):811. PubMed ID: 26523911
[No Abstract] [Full Text] [Related]
10. Role of MR Sequences in the Assessment of Gadolinium-dependent T1 Signal Intensity Increase after Repeated Exposure to Linear Gadolinium-based Contrast Agents.
Quattrocchi CC; Longo D
Radiology; 2017 Jan; 282(1):299-300. PubMed ID: 28005506
[No Abstract] [Full Text] [Related]
11. Interpreting signal-intensity ratios without visible T1 hyperintensities in clinical gadolinium retention studies.
Radbruch A; Quattrocchi CC
Pediatr Radiol; 2017 Nov; 47(12):1688-1689. PubMed ID: 28914340
[No Abstract] [Full Text] [Related]
12. Myocardium at Risk by Early Gadolinium Enhancement MR Imaging: A Moving Target?
Arheden H
JACC Cardiovasc Imaging; 2017 Feb; 10(2):140-142. PubMed ID: 27665164
[No Abstract] [Full Text] [Related]
13. Gadolinium-DTPA enhanced MRI in neonatal osteomyelitis of the cervical spine.
Martijn A; van der Vliet AM; van Waarde WM; van Aalderen WM
Br J Radiol; 1992 Aug; 65(776):720-2. PubMed ID: 1393402
[No Abstract] [Full Text] [Related]
14. [Visualization of multiple neurofibromas using gadolinium-DTPA assisted MRT: a case report].
Kaminsky S; Schulz B
Rontgenblatter; 1988 Dec; 41(12):492-4. PubMed ID: 3145555
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging of acoustic neuromas: the role of gadolinium-DTPA.
Stack JP; Ramsden RT; Antoun NM; Lye RH; Isherwood I; Jenkins JP
Br J Radiol; 1988 Sep; 61(729):800-5. PubMed ID: 3179642
[TBL] [Abstract][Full Text] [Related]
16. Contrast agents in magnetic resonance imaging.
Roux E; De Broe L
J Belge Radiol; 1988; 71(1):31-6. PubMed ID: 3372466
[No Abstract] [Full Text] [Related]
17. [The value of gadolinium-DTPA in the study of the urinary bladder].
Beyer HK; Blümm R; Hötzinger H
Rontgenpraxis; 1988 Feb; 41(2):57-64. PubMed ID: 3363435
[No Abstract] [Full Text] [Related]
18. Magnetic resonance imaging of intracranial tumors using gadolinium-DTPA. Initial experience with fast imaging.
Niendorf HP; Felix R; Laniado M; Schörner W; Kornmesser W; Claussen C
Acta Radiol Suppl; 1986; 369():561-3. PubMed ID: 2980558
[TBL] [Abstract][Full Text] [Related]
19. Assessment of kainate toxicity using contrast enhanced magnetic resonance imaging.
Beravs K; Frangez R; Demsar F
Pflugers Arch; 2000; 440(5 Suppl):R153-4. PubMed ID: 11005651
[TBL] [Abstract][Full Text] [Related]
20. Reply to Radbruch et al.: 'interpreting signal-intensity ratios without visible T1 hyperintensities in clinical gadolinium retention studies'.
Rossi Espagnet MC; Tomà P; Napolitano A
Pediatr Radiol; 2017 Nov; 47(12):1690-1691. PubMed ID: 28884213
[No Abstract] [Full Text] [Related]
[Next] [New Search]
